Home › Funds › ORBIMED ADVISORS LLC › AZN
ORBIMED ADVISORS LLC position in AZN
ASTRAZENECA PLC · Health Care
ORBIMED ADVISORS LLC reported holding 915,700 shares of AZN (ASTRAZENECA PLC) in its Q2 2026 13F filing — a position valued at US$171.1M, representing 3.44% of its reported portfolio and ranking #6 among its reported holdings. ORBIMED ADVISORS LLC has disclosed AZN holdings in 5 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's AZN position evolved
ORBIMED ADVISORS LLC first disclosed a stake in AZN in Q3 2023 at 250,000 shares (US$16.9M). The position peaked in Q2 2026 at 915,700 shares, worth US$171.1M. Across 5 filings, ORBIMED ADVISORS LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 915,700 shares valued at US$171.1M — an increase of 245,500 shares quarter over quarter.. Notable position changes include a 50% increase in Q3 2025 (shares rose 20% over the following quarter), a 37% increase in Q2 2026 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 250.00K | $16.93M | New |
| Q2 2025 | 100.00K | $6.99M | New |
| Q3 2025 | 150.00K | $11.51M | Add |
| Q1 2026 | 670.20K | $132.18M | New |
| Q2 2026 | 915.70K | $171.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AZN and 13F data
AZN (ASTRAZENECA PLC) is a Health Care company. 71 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AZN
- Evelyn Partners Group Ltd 2.24M sh · $41.52B · Q2 2026
- Banque Cantonale Vaudoise 60.46K sh · $11.31B · Q2 2026
- INVESTOR AB 51.59M sh · $9.78B · Q2 2026
- Capital International Investors 34.58M sh · $6.49B · Q2 2026
- Norges Bank Investment Management 33.86M sh · $6.33B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Wellington Management Group 28.54M sh · $5.36B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 28.54M sh · $5.36B · Q2 2026
- Legal & General Investment Management America 25.75M sh · $4.82B · Q2 2026
- VANGUARD ASSET MANAGEMENT, Ltd 18.71M sh · $3.49B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 18.10M sh · $3.43B · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held AZN?
ORBIMED ADVISORS LLC has disclosed AZN holdings in 5 of the last 12 reported quarters, going back to Q3 2023.
What is ORBIMED ADVISORS LLC's current position in AZN?
As of Q2 2026, ORBIMED ADVISORS LLC holds 915.70K shares of AZN (ASTRAZENECA PLC), valued at $171.08M, representing 3.44% of its reported portfolio and ranking #6.
Has ORBIMED ADVISORS LLC been buying or selling AZN?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in AZN. The position peaked in Q2 2026 at 915.70K shares.
Which other funds hold AZN?
Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.